Casanova, J.D.; Carrillo, J.G.; Jiménez, J.M.; Muñoz, J.C.; Esparza, C.M.; Alvárez, M.S.; Escribá, R.; Milla, E.B.; de la Pompa, J.L.; Raya, Á.;
et al. Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences. J. Clin. Med. 2020, 9, 3171.
https://doi.org/10.3390/jcm9103171
AMA Style
Casanova JD, Carrillo JG, Jiménez JM, Muñoz JC, Esparza CM, Alvárez MS, Escribá R, Milla EB, de la Pompa JL, Raya Á,
et al. Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences. Journal of Clinical Medicine. 2020; 9(10):3171.
https://doi.org/10.3390/jcm9103171
Chicago/Turabian Style
Casanova, José David, Josefa González Carrillo, Jesús Martín Jiménez, Javier Cuenca Muñoz, Carmen Muñoz Esparza, Marcos Siguero Alvárez, Rubén Escribá, Esther Burillo Milla, José Luis de la Pompa, Ángel Raya,
and et al. 2020. "Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences" Journal of Clinical Medicine 9, no. 10: 3171.
https://doi.org/10.3390/jcm9103171
APA Style
Casanova, J. D., Carrillo, J. G., Jiménez, J. M., Muñoz, J. C., Esparza, C. M., Alvárez, M. S., Escribá, R., Milla, E. B., de la Pompa, J. L., Raya, Á., Gimeno, J. R., Molina, M. S., & García, G. B.
(2020). Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences. Journal of Clinical Medicine, 9(10), 3171.
https://doi.org/10.3390/jcm9103171